Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CounterCovid imatinib trial in hospitalized adults with COVID-19 hypoxemic respiratory failure
NL-OMON23447Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Imatinib with Placebo (2 arms). Started Mar 2020; status: recruiting.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON23447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23447.